MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $11,710,000 | +51.9% | 194,199 | +15.8% | 0.02% | +50.0% |
| Q1 2016 | $7,708,000 | +17.2% | 167,631 | +23.2% | 0.01% | +9.1% |
| Q4 2015 | $6,579,000 | +99.3% | 136,108 | +75.2% | 0.01% | +83.3% |
| Q3 2015 | $3,301,000 | -50.6% | 77,673 | +32.6% | 0.01% | -53.8% |
| Q2 2015 | $6,688,000 | -11.8% | 58,563 | -0.3% | 0.01% | -13.3% |
| Q1 2015 | $7,583,000 | +71.1% | 58,751 | +32.1% | 0.02% | +66.7% |
| Q4 2014 | $4,431,000 | +2.9% | 44,486 | +2.2% | 0.01% | -10.0% |
| Q3 2014 | $4,305,000 | +33.6% | 43,546 | +4.2% | 0.01% | +42.9% |
| Q2 2014 | $3,222,000 | +45.3% | 41,806 | +21.4% | 0.01% | +40.0% |
| Q1 2014 | $2,217,000 | +5.5% | 34,448 | +4.7% | 0.01% | 0.0% |
| Q4 2013 | $2,101,000 | +27.1% | 32,914 | +19.3% | 0.01% | +25.0% |
| Q3 2013 | $1,653,000 | +21.1% | 27,582 | -0.6% | 0.00% | 0.0% |
| Q2 2013 | $1,365,000 | – | 27,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |